POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
UNI - EN REPORT No | 21 | / | 2020 | ||||||||
Date of issue: | 2020-06-29 | ||||||||||
Short name of the issuer | |||||||||||
KRKA | |||||||||||
Subject | |||||||||||
Acquisition of treasury shares | |||||||||||
Official market - legal basis | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
With a reference to the public notice from 28 July 2017, Krka is publicly disclosing information on transactions relating to buy-back programme in the period from 22 June 2020 up to and including 24 June 2020. Krka acquired 11,170 treasury shares in the total value of EUR 937,683 on the Ljubljana Stock Exchange as follows: - on 22 June 2020: 2,579 shares at a VWAP of EUR 83.80, - on 23 June 2020: 1,182 shares at a VWAP of EUR 83.93 and - on 24 June 2020: 7,409 shares at a VWAP of EUR 84.00. Price is calculated as volume weighted average price (VWAP). Ilirika d.d., NLB d.d. and SKB d.d. were brokers in these transactions. The total number of treasury shares prior to these transactions was 1,423,802 representing 4.342% of all shares issued. The total number of treasury shares after these transactions is 1,434,972 representing 4.376% of all shares issued. | |||||||||||
Annexes | |||||||||||
File | Description |
KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
(fullname of the issuer) | |||||||||||||
KRKA | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
8501 | Nove Mesto | ||||||||||||
(post code) | (city) | ||||||||||||
Smarjeska | 6 | ||||||||||||
(street) | (number) | ||||||||||||
+386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nie dotyczy | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2020-06-29 | Jože Colarič | President of the Management Board |